Dozens of schools and colleges across Minnesota and Wisconsin have announced closures, virtual learning days, or delayed ...
Edited by Joan Strassmann, Washington University in St. Louis, St. Louis, MO; received December 26, 2024; accepted April 11, 2025 ...
Zongertinib gained accelerated approval for unresectable/metastatic HER2 kinase-domain–mutant nonsquamous NSCLC, with 76% ORR and DOR ≥12 months in 44%. AMPLIFY ...
IDEAYA Biosciences (NASDAQ:IDYA) outlined upcoming clinical milestones for its precision oncology pipeline, emphasizing an imminent top-line readout in first-line metastatic uveal melanoma (MUM), ...
Abstract Neutral endopeptidase 24.11, a membrane-bound metallopeptidase, cleaves and degrades vasoactive peptides such as atrial natriuretic peptide, endothelin, angiotensin I, substance P, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results